{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:32:40Z","timestamp":1782743560011,"version":"3.54.5"},"reference-count":22,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The intent of this study is to characterize indications for pediatric palliative\u2010intent proton radiation therapy (PIPRT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Procedure<\/jats:title><jats:p>We retrospectively reviewed patients 21\u00a0years and younger who received PIPRT. We defined PIPRT as radiotherapy (RT) aimed to improve cancer\u2010related symptoms\/provide durable local control in the non\u2010curative setting. Mixed proton\/photon plans were included. Adjacent re\u2010irradiation (reRT) was defined as a reRT volume within the incidental dose cloud of a prior RT target, whereas direct reRT was defined as in\u2010field overlap with prior RT target. Acute toxicity during RT until first inspection visit was graded according to the Common Terminology Criteria for Adverse Events. The Kaplan\u2013Meier method, measured from last PIPRT fraction, was used to assess progression\u2010free survival (PFS) and overall survival (OS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighteen patients underwent PIPRT between 2014 and 2020. Median age at treatment start was 10\u00a0years [2\u201321]. Median follow\u2010up was 8.2\u00a0months [0\u201348]. Treatment sites included: brain\/spine [10], abdomen\/pelvis [3], thorax [3], and head\/neck [2]. Indications for palliation included: durable tumor control [18], neurologic symptoms [4], pain [3], airway compromise [2], and great vessel compression [1]. Indications for protons included: reRT [15] (three adjacent, 12 direct), craniospinal irradiation [4], reduction of dose to normal tissues [3]. Sixteen experienced grade (G) 1\u20132 toxicity; two G3. There were no reports of radionecrosis. Median PFS was 5.3\u00a0months [95% confidence interval (CI): 2.7\u201316.3]. Median OS was 8.3\u00a0months [95% CI: 5.5\u201326.3].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The most common indication for PIPRT was reRT to provide durable tumor control. PIPRT appears to be safe, with no cases of high\u2010grade toxicity.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.30708","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T04:07:49Z","timestamp":1696478869000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Delivery of re\u2010irradiation and complex palliative radiotherapy using proton therapy in pediatric cancer patients"],"prefix":"10.1002","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6427-3062","authenticated-orcid":false,"given":"Eva","family":"Berlin","sequence":"first","affiliation":[{"name":"Children's Hospital of Philadelphia University of Pennsylvania  Philadelphia Pennsylvania USA"},{"name":"Department of Radiation Oncology Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-6478","authenticated-orcid":false,"given":"Rachel","family":"Eisenberg","sequence":"additional","affiliation":[{"name":"Albany Medical College Albany Medical Center  Albany New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hill\u2010Kayser","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia University of Pennsylvania  Philadelphia Pennsylvania USA"},{"name":"Department of Radiation Oncology Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Lustig","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia University of Pennsylvania  Philadelphia Pennsylvania USA"},{"name":"Department of Radiation Oncology Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goldie","family":"Kurtz","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia University of Pennsylvania  Philadelphia Pennsylvania USA"},{"name":"Department of Radiation Oncology Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cummings","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia University of Pennsylvania  Philadelphia Pennsylvania USA"},{"name":"Department of Radiation Oncology Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"LaRiviere","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia University of Pennsylvania  Philadelphia Pennsylvania USA"},{"name":"Department of Radiation Oncology Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02331"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28292"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26589"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/60\/8\/R155"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.10.025"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-73349-6.00024-8"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.2446"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25388"},{"key":"e_1_2_8_10_1","unstructured":"Particle therapy facilities in clinical operation.2022. Accessed November 29 2022.https:\/\/www.ptcog.site\/index.php\/facilities\u2010in\u2010operation\u2010public"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2021.1944180"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.09.015"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4333"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.11.037"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.05.018"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2019.1659996"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.2738"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01148"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01706"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rraa118"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4553"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2014.887225"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.09.049"}],"updated-by":[{"DOI":"10.1002\/pbc.31403","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000}}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.30708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:38:27Z","timestamp":1698068307000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.30708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1002\/pbc.30708"],"URL":"https:\/\/doi.org\/10.1002\/pbc.30708","archive":["Portico"],"relation":{"correction":[{"id-type":"doi","id":"10.1002\/pbc.31403","asserted-by":"object"}]},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"2023-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e30708"}}